Advocacy – National
The NBCC National – Conference and Lobby Day
On May 5th 2012, Advocacy Committee members traveled to Washington, DC to participate in the National Breast Cancer Coalition’s (NBCC) Annual Advocacy Training Conference and Lobby Day. There, they met with Senators and Representatives of local congressional districts. These meetings give Advocacy Committee members the opportunity to educate lawmakers about breast cancer issues and advocate for identified legislation, as well as to hear their questions and feedback on how the legislative climate is addressing, or not addressing, breast cancer issues.
To sign the National Breast Cancer Coalition petition to end breast cancer, click here.
The National Breast Cancer Coalition’s 2012 Legislative and Public Policy Priorities
- Accelerating the End of Breast Cancer Act. Despite years of effort by scientists, we still don’t know what causes much of this disease or how to prevent it, and we needed a plan of action. NBCC has developed an overall breast cancer initiative that will make certain this happens. In November 2010, NBCC launched Breast Cancer Deadline 2020®, a call to action for policymakers, researchers, breast cancer advocates and other stakeholders to end the disease by January 1, 2020.
A vital component of that strategy is bill HR 3067 – Accelerating the End of Breast Cancer Act which was introduced in September 2011 in the House of Representatives. It already has over 100 co-sponsors – including six from our Western half of New York State. A Senate version is close to being introduced. This bill, through the creation of a Commission consisting of the best minds in biomedical research, business, breast cancer advocacy and other related and unrelated disciplines, will focus on identifying strategies to prevent breast cancer from developing AND to prevent metastasis. This Commission will play a major role toward reaching the goal of Breast Cancer Deadline 2020.
- Guaranteed Access to Quality Care for All. For many years now, NBCC has made access to quality health care for all a top priority. The “Patient Protection and Affordable Care Act” passed last year represents a significant step forward towards this goal and provides many important protections for breast cancer survivors. Repealing or invalidating this law would have many direct consequences for breast cancer survivors.
- $150 Million for the Department of Defense Breast Cancer Research Program (BCRP). As a result of NBCC’s grassroots advocacy, the DOD BCRP was created in 1992 to “eradicate breast cancer by funding innovative, high-impact research through a partnership of scientists and consumers.” NBCC seeks continued level funding for this successful program.
- Preservation of the Medicaid Breast and Cervical Cancer Treatment Program. Congress enacted the Breast and Cervical Cancer Treatment Act in 2000 after years of NBCC grassroots lobbying and influence. NBCC remains committed to ensuring all women and men screened and diagnosed with breast cancer through federal screening programs have access to the treatment they need.
- Ensuring the Participation of Educated Patient Advocates in All Levels of Health Care. NBCC continues to work to ensure that educated patient advocates have a “seat at the table” in all levels of health care decision making that affects their lives.
For more information please visit www.stopbreastcancer.org.
Learn about the Advocacy Committee’s work on the Local and State levels.